Body mass index, abdominal fatness and pancreatic cancer risk: A systematic review and non-linear dose-response meta-analysis of prospective studies

Annals of Oncology

Volumn 23, Issue 4, 2012, Pages 843-852

  Aune, D ^a   Greenwood, D C ^b   Chan, D S M ^a   Vieira, R ^a   Vieira, A R ^a   Navarro Rosenblatt, D A ^a   Cade, J E ^b   Burley, V J ^b   Norat, T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Body mass index; Meta analysis; Pancreatic cancer; Systematic review; Waist circumference; Waist to hip ratio

Indexed keywords

ABDOMINAL FAT; ABDOMINAL OBESITY; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONLINEAR SYSTEM; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

BODY MASS INDEX; HUMANS; INCIDENCE; OBESITY, ABDOMINAL; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; WAIST-HIP RATIO;

EID: 84859494180     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr398     Document Type: Review

References (68)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. Washington, DC: AICR 2007.
3. Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
4. Abate N. Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care 1996; 19: 292-294.
5. Berrington de Gonzalez A, Bueno-de-Mesquita HB, Roddam A et al. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006; 15: 879-885.
6. Samanic C, Chow WH, Gridley G et al. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17: 901-909.
7. Nothlings U, Wilkens LR, Murphy SP et al. Body mass index and physical activity as risk factors for pancreatic cancer: the Multiethnic Cohort Study. Cancer Causes Control 2007; 18: 165-175.
8. Luo J, Iwasaki M, Inoue M et al. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a largescale population-based cohort study in Japan-the JPHC study. Cancer Causes Control 2007; 18: 603-612.
9. Verhage BA, Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry and pancreatic cancer risk: an illustration of the importance of microscopic verification. Cancer Epidemiol Biomarkers Prev 2007; 16: 1449-1454.
10. Stolzenberg-Solomon RZ, Adams K, Leitzmann M et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol 2008; 167: 586-597.
11. Jee SH, Yun JE, Park EJ et al. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008; 123: 1892-1896.
12. Luo J, Margolis KL, Adami HO et al. Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer 2008; 99: 527-531.
13. de Martel C, Llosa AE, Friedman GD et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 1188-1194.
14. Meinhold CL, Berrington de Gonzalez A, Albanes D et al. Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers. Cancer Causes Control 2009; 20: 681-690.
15. Johansen D, Borgstrom A, Lindkvist B, Manjer J. Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study within the Malmo Preventive Project. Pancreatology 2009; 9: 677-686.
16. Stevens RJ, Roddam AW, Spencer EA et al. Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer 2009; 124: 2400-2405.
17. Andreotti G, Hou L, Beane Freeman LE et al. Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. Cancer Causes Control 2010; 21: 1759-1775.
18. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
19. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003; 89: 519-523.
20. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer 2007; 120: 1993-1998.
21. Friedman GD, van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 1993; 22: 30-37.
22. Shibata A, Mack TM, Paganini-Hill A et al. A prospective study of pancreatic cancer in the elderly. Int J Cancer 1994; 58: 46-49.
23. Zheng W, Doyle TJ, Kushi LH et al. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 1996; 144: 175-182.
24. Tulinius H, Sigfusson N, Sigvaldason H et al. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997; 6: 863-873.
25. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999; 91: 535-541.
26. Robsahm TE, Tretli S. Height, weight and gastrointestinal cancer: a follow-up study in Norway. Eur J Cancer Prev 1999; 8: 105-113.
27. Nilsen TI, Vatten LJ. A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trondelag, Norway. Cancer Causes Control 2000; 11: 645-652.
28. Michaud DS, Giovannucci E, Willett WC et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286: 921-929.
29. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR et al. A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 2002; 13: 417-426.
30. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR et al. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002; 155: 783-792.
31. Isaksson B, Jonsson F, Pedersen NL et al. Lifestyle factors and pancreatic cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 2002; 98: 480-482.
32. Anderson KE, Johnson TW, Lazovich D, Folsom AR. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 2002; 94: 1168-1171.
33. Stolzenberg-Solomon RZ, Limburg P, Pollak M et al. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. Cancer Epidemiol Biomarkers Prev 2004; 13: 438-444.
34. Rapp K, Schroeder J, Klenk J et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 2005; 93: 1062-1067.
35. Kuriyama S, Tsubono Y, Hozawa A et al. Obesity and risk of cancer in Japan. Int J Cancer 2005; 113: 148-157.
36. Larsson SC, Permert J, Hakansson N et al. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 2005; 93: 1310-1315.
37. Sinner PJ, Schmitz KH, Anderson KE, Folsom AR. Lack of association of physical activity and obesity with incident pancreatic cancer in elderly women. Cancer Epidemiol Biomarkers Prev 2005; 14: 1571-1573.
38. Patel AV, Rodriguez C, Bernstein L et al. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev 2005; 14: 459-466.
39. Navarro Silvera SA, Miller AB, Rohan TE. Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study. Pancreas 2005; 30: 369-374.
40. Nothlings U, Wilkens LR, Murphy SP et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst 2005; 97: 1458-1465.
41. Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 2005; 23: 4742-4754.
42. Lukanova A, Bjor O, Kaaks R et al. Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2006; 118: 458-466.
43. Yun JE, Jo I, Park J et al. Cigarette smoking, elevated fasting serum glucose, and risk of pancreatic cancer in Korean men. Int J Cancer 2006; 119: 208-212.
44. Reeves GK, Pirie K, Beral V et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134.
45. Berrington de Gonzalez A, Yun JE, Lee SY et al. Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev 2008; 17: 359-64.
46. Jiao L, Mitrou PN, Reedy J et al. A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch Intern Med 2009; 169: 764-770.
47. Andreotti G, Freeman LE, Hou L et al. Agricultural pesticide use and pancreatic cancer risk in the Agricultural Health Study Cohort. Int J Cancer 2009; 124: 2495-2500.
48. Gapstur SM, Gann PH, Lowe W et al. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000; 283: 2552-2558.
49. Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000; 11: 915-923.
50. Lee IM, Sesso HD, Oguma Y, Paffenbarger RS Jr. Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer 2003; 88: 679-683.
51. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
52. Batty GD, Shipley MJ, Marmot M, Smith GD. Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study. Cancer Causes Control 2004; 15: 873-881.
53. Lin Y, Kikuchi S, Tamakoshi A et al. Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer 2007; 120: 2665-2671.
54. Batty GD, Kivimaki M, Morrison D et al. Risk factors for pancreatic cancer mortality: extended follow-up of the original Whitehall Study. Cancer Epidemiol Biomarkers Prev 2009; 18: 673-675.
55. Arnold LD, Patel AV, Yan Y et al. Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomarkers Prev 2009; 18: 2397-2405.
56. Nakamura K, Nagata C, Wada K et al. Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: a prospective cohort study in Japan. Jpn J Clin Oncol 2011; 41: 225-231.
57. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
58. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309.
59. Chene G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 1996; 144: 610-621.
60. Bagnardi V, Zambon A, Quatto P, Corrao G. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 2004; 159: 1077-1086.
61. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
62. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
63. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
64. Arslan AA, Helzlsouer KJ, Kooperberg C et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 2010; 170: 791-802.
65. Jiao L, Berrington de Gonzalez A, Hartge P et al. Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control 2010; 21: 1305-1314.
66. Genkinger JM, Spiegelman D, Anderson KE et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 2011; 129: 1708-1717.
67. Rimm EB, Stampfer MJ, Colditz GA et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990; 1: 466-473.
68. Weaver TW, Kushi LH, McGovern PG et al. Validation study of self-reported measures of fat distribution. Int J Obes Relat Metab Disord 1996; 20: 644-650.